Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0MD4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,116
Award facts
- Contract value 100% obligated
- $66,115.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $66,115.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens (2 ml), a biologic medication used to treat atopic dermatitis, eosinophilic asthma, and other inflammatory conditions. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026, and represents a non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement to fulfill this medical supply requirement for the federal government's defense healthcare systems.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.999 billion through December 31, 2031. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving entities including the Defense Health Agency and the U.S. Coast Guard. The award demonstrates AmerisourceBergen's established capability to efficiently deliver specialized pharmaceutical commodities through the DLA's medical supply chain to support federal military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F0MD4?
SPE2DR26F0MD4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F0MD4 worth?
The government has obligated $66,116 on SPE2DR26F0MD4.
Is contract SPE2DR26F0MD4 an order under another contract?
Yes. SPE2DR26F0MD4 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0MD4 competed?
The extent of competition for SPE2DR26F0MD4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award